318 related articles for article (PubMed ID: 28646657)
21. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.
Qi J; Liang S; Gou Y; Zhang Z; Zhou Z; Yang F; Liang H
Eur J Med Chem; 2015; 96():360-8. PubMed ID: 25899339
[TBL] [Abstract][Full Text] [Related]
22. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
23. The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexes.
Liu X; Lv A; Zhang P; Chang J; Dong R; Liu M; Liu J; Huang X; Yuan XA; Liu Z
Dalton Trans; 2024 Jan; 53(2):552-563. PubMed ID: 38054240
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
25. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH
J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
27. Ferrocene-conjugated L-tryptophan copper(II) complexes of phenanthroline bases showing DNA photocleavage activity and cytotoxicity.
Goswami TK; Chakravarthi BV; Roy M; Karande AA; Chakravarty AR
Inorg Chem; 2011 Sep; 50(17):8452-64. PubMed ID: 21797197
[TBL] [Abstract][Full Text] [Related]
28. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.
Yellol J; Pérez SA; Yellol G; Zajac J; Donaire A; Vigueras G; Novohradsky V; Janiak C; Brabec V; Ruiz J
Chem Commun (Camb); 2016 Dec; 52(98):14165-14168. PubMed ID: 27869279
[TBL] [Abstract][Full Text] [Related]
29. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, antiproliferative activity and mechanism of gallium(III)-thiosemicarbazone complexes as potential anti-breast cancer agents.
Qi J; Yao Q; Qian K; Tian L; Cheng Z; Yang D; Wang Y
Eur J Med Chem; 2018 Jun; 154():91-100. PubMed ID: 29777989
[TBL] [Abstract][Full Text] [Related]
31. Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts.
Geldmacher Y; Splith K; Kitanovic I; Alborzinia H; Can S; Rubbiani R; Nazif MA; Wefelmeier P; Prokop A; Ott I; Wölfl S; Neundorf I; Sheldrick WS
J Biol Inorg Chem; 2012 Apr; 17(4):631-46. PubMed ID: 22358334
[TBL] [Abstract][Full Text] [Related]
32. Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.
Zhang Z; Gou Y; Wang J; Yang K; Qi J; Zhou Z; Liang S; Liang H; Yang F
Eur J Med Chem; 2016 Oct; 121():399-409. PubMed ID: 27309677
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex.
Parsa FG; Feizi MAH; Safaralizadeh R; Hosseini-Yazdi SA; Mahdavi M
J Biol Inorg Chem; 2020 May; 25(3):383-394. PubMed ID: 32274578
[TBL] [Abstract][Full Text] [Related]
34. Antiproliferative and proapoptotic activity of molecular copper(II) complex of N-1-tosylcytosine.
Glavaš-Obrovac L; Jukić M; Mišković K; Marković I; Saftić D; Ban Ž; Matić J; Žinić B
J Trace Elem Med Biol; 2019 Sep; 55():216-222. PubMed ID: 29066001
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4'-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2':6',2″-terpyridine.
Chu W; Wang Y; Liu S; Yang X; Wang S; Li S; Zhou G; Qin X; Zhou C; Zhang J
Bioorg Med Chem Lett; 2013 Sep; 23(18):5187-91. PubMed ID: 23927970
[TBL] [Abstract][Full Text] [Related]
36. Selenium-containing naphthalimides as anticancer agents: design, synthesis and bioactivity.
Zhao L; Li J; Li Y; Liu J; Wirth T; Li Z
Bioorg Med Chem; 2012 Apr; 20(8):2558-63. PubMed ID: 22436386
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
40. Studies on the cytotoxicity and anticancer performance of heterocyclic hypervalent organobismuth(III) compounds.
Liu YP; Lei J; Tang LW; Peng Y; Au CT; Chen Y; Yin SF
Eur J Med Chem; 2017 Oct; 139():826-835. PubMed ID: 28865278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
